Qiangling Yin
Chinese Center for Disease Control and Prevention
10 Papers
21 Citations
Qiangling Yin is an academic researcher from Chinese Center for Disease Control and Prevention. The author has contributed to research in topics: Antibody & Neutralization. The author has an hindex of 2, co-authored 6 publications.
Chat about Author
Papers
Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants
Jia Lu,Qiangling Yin,Rongjuan Pei,Qiuyan Zhang,Yuan-Qing Qu,Yongbing Pan,Lina Sun,Ding Gao,Cuiqin Liang,Jin-Kui Yang,Wei Wu,Jiandong Li,Zongqiang Cui,Zejun Wang,Xinguo Li,Dexin Li,Shiwen Wang,Kai Duan,Wuxiang Guan,Mifang Liang,Xiaoming Yang +20 more
TL;DR: In this paper , the nasal delivery of two previously characterized broadly neutralizing antibodies (F61 and H121) protected K18-hACE2 mice against lethal challenge with SARS-CoV-2 variants.
28
Abnormal Upregulation of Cardiovascular Disease Biomarker PLA2G7 Induced by Proinflammatory Macrophages in COVID-19 patients
Yang Li,Yongzhong Jiang,Yi Zhang,Naizhe Li,Qiangling Yin,Linlin Liu,Xin Lv,Yan Liu,Aqian Li,Bin Fang,Jiajia Li,Hengping Ye,Gang Yang,Xiaoxian Cui,Yang Liu,Yuanyuan Qu,Chuan Li,Jiandong Li,Dexin Li,Shiwen Wang,Zhongtao Gai,Faxian Zhan,Mifang Liang +22 more
TL;DR: PLA2G7, a biomarker for cardiovascular diseases (CVDs), was abnormally enhanced in COVID-19 patients at both nucletide and protein aspects and provided indications into the prevalence of cardiovascular involvements seen in COIDs patients.
22
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages
Xiaoman Li,Yongbing Pan,Qiangling Yin,Zejun Wang,Sisi Shan,Laixing Zhang,Jinfang Yu,Yuan-Qing Qu,Lina Sun,Fang Gui,Jia Lu,Zhaofei Jing,Wei Wu,Tao Huang,Xuanling Shi,Jiandong Li,Xinguo Li,Dexin Li,Shiwen Wang,Maojun Yang,Linqi Zhang,Kai Duan,Mifang Liang,Xiaoming Yang,Xinquan Wang +24 more
TL;DR: In this paper , the authors characterized the previously reported F61, which was isolated from convalescent patients infected with prototype SARS-CoV-2, as a broadly neutralizing antibody against all VOCs including Omicron BA.1, BA.2 and BA.4 sublineages by utilizing antigen binding and cell infection assays.
Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.
Yuanyuan Qu,Xueyan Zhang,Meiyu Wang,Lina Sun,Yongzhong Jiang,Cheng Li,Wei Wu,Zhen Chen,Qiangling Yin,Xiaolin Jiang,Yang Liu,Chuan Li,Jiandong Li,Tianlei Ying,Dexin Li,Faxian Zhan,Youchun Wang,Wuxiang Guan,Shiwen Wang,Mifang Liang +19 more
TL;DR: In this article, two RBD-binding antibodies (F61 and H121) showed high affinity neutralization against SARS-CoV-2, whereas three S2-target antibodies failed to neutralize SARS CoV2.
13
Hemorrhagic Fever with Renal Syndrome - Liaoning Province, China, 1999-2018.
Cui Shang,Yingwei Sun,Qiangling Yin,Xiaoxia Huang,Xuesheng Liu,Quanfu Zhang,Lingling Mao,Chuan Li,Aqian Li,Qin Wang,Lina Sun,Mifang Liang,Shiwen Wang,Dexin Li,Jiandong Li +14 more
- 01 May 2020
TL;DR: The epidemic trend of HFRS over the past 20 years in Liaoning was analyzed, which showed both regional complexity and consistence with the epidemic in China, and genetic and antigenic stability of the circulating hantavirus were demonstrated.
11